Skip to main content
. 2019 Jun 10;15(8):1712–1722. doi: 10.7150/ijbs.33986

Figure 2.

Figure 2

Receiver-operator characteristic (ROC) curve analyses of 5 serum miRNAs. MiR-146b, miR-205, miR-29c, miR-30b, and miR-337, is differentially expressed in NSCLC patients compared to either healthy controls in the training set (TR, shown in solid line) or cancer-free controls in the testing set (TS, shown in dotted line).